Abstract
The present application provides a compound that inhibits TRAP1 or a pharmaceutically acceptable salt thereof. In this case, the compound or pharmaceutically acceptable salt thereof may inhibit binding between TRAP1 and the client protein. Furthermore, the present application provides: a pharmaceutical composition comprising a compound that inhibits TRAP1, or a pharmaceutically acceptable salt thereof, for use in the treatment of cancer or an ocular disease, and uses thereof.
https://patents.google.com/patent/CN117769559A/en?oq=CN+117769559+A